Jump to content

Dextroamphetamine: Revision history


For any version listed below, click on its date to view it. For more help, see Help:Page history and Help:Edit summary. (cur) = difference from current version, (prev) = difference from preceding version, m = minor edit, → = section edit, ← = automatic edit summary

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

3 November 2024

2 November 2024

  • curprev 02:4302:43, 2 November 2024 Slothwizard talk contribs 59,977 bytes −509 Like I said before, using dex for negative symptoms of schizophrenia is not a notable indication and shouldn’t be on lede. There are other more common off-label uses for dex, and they should not be on the lede either. Please go to discussions if there is disagreement, thanks undo Tags: Visual edit Mobile edit Mobile web edit

30 October 2024

25 October 2024

23 October 2024

9 October 2024

1 October 2024

27 September 2024

26 September 2024

  • curprev 23:1723:17, 26 September 2024 Slothwizard talk contribs 59,893 bytes −447 This indication is just from a research paper, this is not an approved nor common off-label use of dex, especially given that it can worsen psychosis. Dextroamphetamine is also off-label antidepressant, but that doesn’t mean we should put that in lede. Also, using it for depression is more common than negative symptoms of schizophrenia by far anyways undo Tags: Visual edit Mobile edit Mobile web edit

22 September 2024

21 September 2024

20 September 2024

19 September 2024

16 September 2024

13 September 2024

12 September 2024

17 August 2024

3 August 2024

25 July 2024

10 July 2024

8 July 2024

5 July 2024

28 June 2024

20 June 2024

11 June 2024

8 June 2024

4 June 2024

27 May 2024

9 May 2024

19 April 2024

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)